Symbol="CBAY"
AssetType="Common Stock"
Name="Cymabay Therapeu"
Description="CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and delivering therapies to treat liver and other chronic diseases. The company is headquartered in Newark, California."
CIK="1042074"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="3876 BAY CENTER PLACE, HAYWARD, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="1218915000"
EBITDA="-94744000"
PERatio="None"
PEGRatio="0"
BookValue="1.07"
DividendPerShare="0"
DividendYield="0"
EPS="-1.2"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.268"
ReturnOnEquityTTM="-1.012"
RevenueTTM="0"
GrossProfitTTM="-41635000"
DilutedEPSTTM="-1.2"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="16"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="5.76"
EVToRevenue="-"
EVToEBITDA="-3.032"
Beta="0.377"
num_52WeekHigh="13.25"
num_52WeekLow="3.155"
num_50DayMovingAverage="10.34"
num_200DayMovingAverage="7.88"
SharesOutstanding="97513000"
DividendDate="None"
ExDividendDate="None"
symbol="CBAY"
open="12.40"
high="12.76"
low="12.13"
price="12.63"
volume="1678706.00"
latest_trading_day="2023-08-09"
previous_close="12.40"
change="0.23"
change_percent="1.8548%"
aroon_positive_momentum_days="85"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="85"
Volume_recent_avg="1765929"
Change_recent_avg="0.01"
Delta_recent_avg="0.51"
Variance_recent_avg="0.25"
Change_ratio_recent_avg="-0.05"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="85"
Aroon_momentum_negative="15"
image_negative_thumbnail_id_1="492"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0113.jpeg"
image_negative_thumbnail_id_2="1120"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0153.jpeg"
image_neutral_thumbnail_id_1="592"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0007.jpeg"
image_neutral_thumbnail_id_2="580"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0019.jpeg"
image_positive_thumbnail_id_1="998"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0160.jpeg"
image_positive_thumbnail_id_2="979"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0141.jpeg"
image_professor_thumbnail_id_1="1189"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0023.jpeg"
image_professor_thumbnail_id_2="1173"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0007.jpeg"
